LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 194 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $2,046,000 | -21.8% | 18,300 | -49.2% | 0.02% | -44.7% |
| Q1 2020 | $2,617,000 | -34.0% | 36,000 | -5.3% | 0.04% | -17.4% |
| Q4 2019 | $3,963,000 | -47.1% | 38,000 | -49.5% | 0.05% | -51.6% |
| Q3 2019 | $7,485,000 | +358.6% | 75,200 | +425.9% | 0.10% | +352.4% |
| Q2 2019 | $1,632,000 | -58.4% | 14,300 | -54.2% | 0.02% | -60.4% |
| Q1 2019 | $3,922,000 | +8813.6% | 31,200 | +8154.0% | 0.05% | – |
| Q2 2016 | $44,000 | +193.3% | 378 | +384.6% | 0.00% | – |
| Q3 2015 | $15,000 | +50.0% | 78 | +2.6% | 0.00% | – |
| Q2 2015 | $10,000 | +25.0% | 76 | +130.3% | 0.00% | – |
| Q1 2015 | $8,000 | -93.2% | 33 | -91.8% | 0.00% | -100.0% |
| Q4 2014 | $117,000 | +105.3% | 402 | +323.2% | 0.00% | +100.0% |
| Q3 2014 | $57,000 | – | 95 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
| Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
| VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
| Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
| Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
| Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
| WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
| Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |